Bipolar Flashcards

1
Q

Background Info of BP I:

  1. Prevalence: __ to __% (narrow vs spectrum)
  2. Onset in young adulthood (if BP develops in people >60 years, it may be from a general ___ disorder that should be first consideration)
  3. Chronic episodic course
  4. Significant ___ (disability, hospitalization, adjustment, substance problems, psychiatric disorder, medical issues)
  5. Significant ____ (suicide, accidents, and medical co-morbidities)
A

Background Info of BP I:

  1. Prevalence: 1 to 4% (narrow vs spectrum)
  2. Onset in young adulthood (if BP develops in people >60 years, it may be from a general medical disorder that should be first consideration)
  3. Chronic episodic course
  4. Significant morbidity (disability, hospitalization, adjustment, substance problems, psychiatric disorder, medical issues)
  5. Significant mortality (suicide, accidents, and medical co-morbidities)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Patients with bipolar I have had at least ___ manic episode (lasting at least ___ wk) that includes at least ____ of the DIG FAST criteria.

DIG FAST (for BP I and II)

  1. ___- poorly focused, multitasking
  2. ___ - decreased need for sleep
  3. ___ - inflated self-esteem
  4. __ of ___ - complaints of racing thoughts
  5. Activity, Agitation, such as putting in significantly more work into projects or increase in sexual activity
  6. ___ – pressured, rapid more talkative speech
  7. ____– engaging in pleasurable activities with negative consequences, such as gambling, driving, sexual, shopping sprees

Manic episode (can last up to __ months if untreated) leads to marked impairment in function or there are psychotic features

A

Patients with bipolar I have had at least one manic episode (lasting at least 1 wk) that includes at least three of the DIG FAST criteria.

DIG FAST (for BP I and II)

  1. Distractibility - poorly focused, multitasking
  2. Insomnia - decreased need for sleep
  3. Grandiosity - inflated self-esteem
  4. Flight of ideas - complaints of racing thoughts
  5. Activity, Agitation, such as putting in significantly more work into projects or increase in sexual activity
  6. Speech – pressured, rapid more talkative speech
  7. Thoughtlessness – engaging in pleasurable activities with negative consequences, such as gambling, driving, sexual, shopping sprees

Manic episode (can last up to 3 months if untreated) leads to marked impairment in function or there are psychotic features

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

___ - A milder form of BP, lasting at least __ years, fluctuating between mild depressive and hypomanic symptoms

A

Cyclothymia - A milder form of BP, lasting at least 2 years, fluctuating between mild depressive and hypomanic symptoms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Bipolar II:

Symptoms: _____ episode = DIGFAST, but no ___ features, not severe enough to cause marked impairment in function or hospitalization

Episode of Major Depression = SIGECAPS Elevated, expansive, irritable mood for __ days.

These patients may have stories similar to those with bipolar I, but they have never had a ___ episode. Instead, they have had at least ___ major ___ episodes and at least one ____ episode.

A __ episode only needs to last __ days (unlike 7 for a manic episode) and is ___ severe than a manic episode.

These patients have DIG FAST symptoms, but are not as severely impaired.

I.E. Think of a college student who has been irritable for the past few days, speaks quickly with rapidly changing topics, and has been spending all the time working on a project for a robotics class, even foregoing sleep.

A

Bipolar II:

Symptoms: hypomanic episode = DIGFAST, but no psychotic features, not severe enough to cause marked impairment in function or hospitalization

Episode of Major Depression = SIGECAPS Elevated, expansive, irritable mood for 4 days.

These patients may have stories similar to those with bipolar I, but they have never had a manic episode. Instead, they have had at least one major hypomanic episodes and at least one depressive episode.

A hypomanic episode only needs to last 4 days (unlike 7 for a manic episode) and is less severe than a manic episode.

These patients have DIG FAST symptoms, but are not as severely impaired.

I.E. Think of a college student who has been irritable for the past few days, speaks quickly with rapidly changing topics, and has been spending all the time working on a project for a robotics class, even foregoing sleep.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Epidemiolgoy of BP:

Lifetime prevalence (adults)

Bipolar I: __ to ___%

Bipolar II: __ to __ % (Both may be underestimates)

Age of onset:

Mean age __ years (up to 25) Peak age __ to ___ years

Gender

Bipolar I male ___ female

Bipolar II female ___ male

A
**Epidemiolgoy of BP:**
_Lifetime prevalence (adults)_

Bipolar I: 0.8% to 1.6%

Bipolar II: 0.5% to 5.5% (Both may be underestimates)

Age of onset:

Mean age 21 years (up to 25) Peak age 15 to 19 years

Gender

Bipolar I male = female

Bipolar II female > male

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Comorbidities:

  1. ___ ___: up to 60%
  2. ____: 42%
  3. ____ phobia: 18-40%
  4. __ __ __: 7.4-35.0%
  5. __ disorders: 5%
  6. ___ headaches: 8.6-44.0%
A

Comorbidities:

  1. Substance abse: up to 60%
  2. Anxiety: 42%
  3. Social phobia: 18-40%
  4. Obsessive Compulsive Disorder: 7.4-35.0%
  5. Eating disorders: 5%
  6. Migraine headaches: 8.6-44.0%
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q
  • *Bipolar Etiology:**
    1. ____—90% concordance in identical twins
  1. Decreased activity in ___ ___ cortex leading to trouble with volitional affect regulation (a will to commit or do something).
  2. Decreased activity in ___ ___ cortex leading to trouble with executive function
  3. Abnormalities in ___ ___ cortex leading to trouble with affect regulation (affect regulation, or emotion regulation, is the ability of an individual to modulate their emotional state in order to adaptively meet the demands of their environment).
  4. Smaller ___ volume
  5. Smaller ____ volume leading to difficulty with assessment and interpretation of emotion and disproportionate emotional responses
A
  • *Etiology:**
    1. Genetics—90% concordance in identical twins
  1. Decreased activity in ventrolateral prefrontal cortex leading to trouble with volitional affect regulation
  2. Decreased activity in dorsilateral prefrontal cortex leading to trouble with executive function
  3. Abnormalities in anterior cingulate cortex leading to trouble with affect regulation
  4. Smaller hippocampal volume
  5. Smaller amygdala volume leading to difficulty with assessment and interpretation of emotion and disproportionate emotional responses
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Consequences of BP:

  1. Impaired _____
  2. Disrupted _____
  3. On average men with ___ years shorter life span and women ___ years
  4. High ____ rate (___%)
  5. ____disasters
  6. Alcohol and other substance ___
A

Consequences of BP:

  1. Impaired functioning
  2. Disrupted relationships
  3. On average men with 11 years shorter life span and women 10 years
  4. High suicide rate (19%)
  5. Financial disasters
  6. Alcohol and other substance abuse
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Treatments or BP:

  1. _____: cognitive-behavioral, interpersonal
  2. Mood ____ +/- anti___, benzos
    - Antipsychotics (can lead to ____ syndromes, obesity, ___ gain, DM)

Medications: OR-ZAQ

  1. ____
  2. ____
  3. ____
  4. ____
  5. ____
  6. ____ ___ ____ for severe depression, psychosis
  7. Combo ___ + medications
  8. Medications for Acute Mania

FDA approved: L____, C____, V_____, D____, Thorazine, Olanzapine, Risperidone, Ziprasidone, Aripiprazol, Quetiapine

A

Treatments or BP:

  1. Psychotherapy: cognitive-behavioral, interpersonal
  2. Mood stabalizer +/- antipsychotics, benzos
    - Antipsychotics (can lead to metabolic syndromes, obesity, weight gain, DM)

Medications: OR-ZAQ

  1. Olanzapine
  2. Risperidone
  3. Zisprasidone
  4. Aripriprazole
  5. Quetiapine
  6. Electroconvulsive therapy for severe depression, psychosis
  7. Combo psychotherapy + medications
  8. Medications for Acute Mania

FDA approved: Lithium, Carbamezapine, Valproate, Divalproex, Thorazine, Olanzapine, Risperidone, Ziprasidone, Aripiprazol, Quetiapine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Metabolic Side Effects of BP Meds

  1. ____ obesity
  2. _____ dyslipidemia (blood fat disorders — high triglycerides, low HDL cholesterol and high ___ cholesterol)
  3. Elevated __ __
  4. ___resistance or ___ intolerance
  5. ___ state (e.g., high fibrinogen or plasminogen activator inhibitor–1)
  6. ____ state (e.g., elevated __-reactive protein)
A

Metabolic Side Effects of BP Meds

  1. Abdominal obesity
  2. Atherogenic dyslipidemia (blood fat disorders — high triglycerides, low HDL cholesterol and high LDL cholesterol)
  3. Elevated blood pressure
  4. Insulin resistance or glucose intolerance
  5. Prothrombotic state (e.g., high fibrinogen or plasminogen activator inhibitor–1)
  6. Proinflammatory state (e.g., elevated C-reactive protein)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Side Effect of BP Meds –> EPS - Extrapyramindal Syndromes

  1. ____— a subjective feeling of restlessness
  2. ___ ___ reactions—abrupt onset muscular spasms of the neck, eyes, trunk, extremities*
  3. ____—stiffness, tremor, impaired gait *Chronic dopamine blockade can lead to __ __.
A

Side Effect of BP Meds –> EPS - Extrapyramindal Syndromes

  1. Akathsia— a subjective feeling of restlessness
  2. Acute dystonic reactions—abrupt onset muscular spasms of the neck, eyes, trunk, extremities*
  3. Parkinsonism—stiffness, tremor, impaired gait *Chronic dopamine blockade can lead to tardive dyskinesia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

BP Med Side Effects (usually caused by atypical bp meds)

NMS - __ ___ __

  1. ____ (0.01%) reaction to dopamine antagonists
  2. Hyper____, hyper___, profuse ___ (sweating)
  3. Lead pipe ____, _____ (breakdown of muscle tissue), tremor
  4. ___ ___ levels 4x upper limit of normal 10-20% mortality if unrecognized

*Reported with essentially every ___or ___ antagonist including non-psychotropics such as ____ (Reglan)

A

BP Med Side Effects:

NMS - Neuroleptic Malignant Syndromes

  1. Idiosyncrasy (0.01%) reaction to dopamine antagonists
  2. Hyperthermia, hypertension, profuse diaphoresis (sweating)
  3. Lead pipe rigidity, rhabdomyolosis (breakdown of muscle tissue), tremor
  4. Elevated CK levels 4x upper limit of normal 10-20% mortality if unrecognized

*Reported with essentially every D1 or D2 antagonist including non-psychotropics such as metoclopramide (Reglan)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

A BP Med Side Effect:

__ ___: A movement disorder that may occur following long-term treatment with antipsychotic medications.

Movements may include:

  • __ and __ movements (lip smacking, sucking and puckering as well as facial grimacing)
  • irregular movements of the limbs, particularly choreoathetoid-like movements of the fingers and toes
  • slow, writhing movements of the trunk - mild- disabling - often irreversible.
A

A BP Med Side Effect:

Tardive Dyskinesia: A movement disorder that may occur following long-term treatment with antipsychotic medications.

Movements may include:

  • Mouth and tongue movements (lip smacking, sucking and puckering as well as facial grimacing)
  • irregular movements of the limbs, particularly choreoathetoid-like movements of the fingers and toes
  • slow, writhing movements of the trunk - mild- disabling - often irreversible.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Tardive Dyskinesia - movement disorder due to _____ use.

Presentation: commonly observed symptoms are chewing movements, lip-smacking, and rolling of the tongue inside mouth and up against the cheek. The limbs and trunk may also be affected.

A history of use of ___-___ blocking drugs is essential to the diagnosis.

___-____ (including haloperidol) are the most common causes of drug-induced movement disorders.

The propensity of a drug to cause these movement disorders is related to its __-___ blocking activity.

A

Tardive Dyskinesia - movement disorder due to neuroepileptic use.

Presentation: commonly observed symptoms are chewing movements, lip-smacking, and rolling of the tongue inside mouth and up against the cheek. The limbs and trunk may also be affected.

A history of use of dopamine receptor blocking drugs is essential to the diagnosis.

Anti-psychotics (including haloperidol) are the most common causes of drug-induced movement disorders.

The propensity of a drug to cause these movement disorders is related to its D2-receptor blocking activity.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

FDA aproved drugs for Acute Mania are:

A

LCD TOR ZAQ

Lithium
Carbamezapine
Divalproex (for younger kids)
Thorazine
Olanzapine
Risperidone
Ziprasidone
Aripriprazole
Quetiapine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

VALPROATE S/Es:

V.A.L.P.R.O.A.T.E.

A

VALPROATE

Valproate

Appetite increase, so weight gain

Liver failure (monitor LFTs during 1st 6 months)

Pancreatitis

Reversible hair loss (grows back curly, apparently)

Oedema

Ataxia

Teratogenicity, Tremor, Thrombocytopaenia

Encephalopathy (due to hyperammonaemia) / Enzyme inducer

17
Q

Carbamezapine S/Es

HARD DG SAND

A

HARD D(irty)G(round) SAND

H/A

Ataxia

Renal toxicitiy

Double vision

Dermatological issues

GI distress

Sedations

Agranulocytosis

Nausea

Dizziness

Biggest S/E is aplastic anemia or agranulocytosis

Must monoiter blood levels and CBC, platelets, LFTs

18
Q

Metabolic Syndromes from Antipsychotics:

BI PPO(lar) D(isorder)

A

elevated BP

insulin resistance

prothrombotic state

Proinflammatory state

Abdominal obesity

Dyslipidemia

19
Q

EPS syndromes

A

4 A’s of EPS (extrapyramidal symptoms)

2/2 TYPICAL antipsychotic use.

These side effects occur at the indicated times following initiation of therapy.

4 hours - Acute dystonia (Tx with anticholinergics)
4 days - Akinesia (Parkinson-like syndrome) Tx w/ dopamine agonists
4 weeks - Akathesia (inability to sit still/continuous movement/restlessness)
4 months - tArdive dyskinesia (often permanent)

20
Q

NMS presenation:

A

S H A CK A

Stiff (Lead pipe rigidity)

Hot (hyperthermia, hypertension, hyper diaphoresis)

Altered mental status

Elevated CK from Rhabdomyolosis

Autonomic instability (vitals unstable)

21
Q

Serotonin Syndrome:

A

Use SHIVERS to recall serotonin syndrome features

S hivering, one of the neuromuscular symptoms unique to SS, helps distinguish it from other hyperthermic syndromes

H yperreflexia and myoclonus are frequently seen in mild to moderate cases and are especially notable in the lower extremities; muscular rigidity occurs only in more severe cases

I ncreased temperature, although variable in SS and usually observed in severe cases, is likely caused by muscular hypertonicity

V ital sign instability can present as tachycardia, tachypnea, and/or labile blood pressure

E ncephalopathy—characterized by mental status changes such as agitation, delirium, confusion, and to a lesser extent obtundation—can develop from hyperthermia

R estlessness and incoordination are common because of excess serotonin activity

S weating (diaphoresis) is an autonomic response to excessive serotonin stimulation; by comparison, anticholinergic toxicity usually manifests with hot, dry skin

22
Q

SNRI S/Es

A

Vexed & Depressed

Vexed – Venlafaxine

Depressed – Duloxetine & Desvenlafaxine (active metabolite of venlafaxine) — Dulexetine
Indications of SNRIs: Generalized Anxiety Disorder (Vexed) and Major Depressive Disorder (Depressed)

Adverse effects:

SHAT:

Same adverse effects as SSRI’s, plus

Hypertension

Adrenergic effects (awake [insomnia], anxious, agitated)

Tachycardia

23
Q

S/E of Lithium

A

LITHI-C

Leukocytosis

Intentional tremor

Teratogenicity

Hypothyroidism

Diabetes Insipidus

Convulsions

24
Q

Patients with treatment-resistant schizophrenia can be treated with _____. This agent is reserved for treatment-resistant schizophrenia due to the risk of agranulocytosis.

A

Patients with treatment-resistant schizophrenia can be treated with clozapine. This agent is reserved for treatment-resistant schizophrenia due to the risk of agranulocytosis.

25
Q

The preferred drugs used to treat Panic disorder are:

___ (first line)

___ (SNRIs)

____

Cognitive Behavioral Therapy (CBT)

A

The preferred drugs used to treat Panic disorder are:

SSRIs (first line)

Venlafaxine (SNRIs)

Benzodiazepines

Cognitive Behavioral Therapy (CBT)

26
Q

Serious adverse effects of TCAs include:3 C’s and the RH

Respiratory depression

Hyperpyrexia

A

A:

Serious adverse effects of TCAs include:3 C’s:

Convulsions

Coma

Cardiotoxicity (due to blockade of fast Na+ channels)

Respiratory depression

Hyperpyrexia

27
Q

The following medications are the preferred drugs used to treat anxiety: SS BBB P

A

The following medications are the preferred drugs used to treat anxiety:

SSRIs

SNRIs

Buspirone

Benzodiazepines (only used to lessen anxiety while SSRIs take effect, then tapered off)

Beta blockers

Pregabalin

28
Q

The combination of an MAOI and SSRI can precipitate a dangerous serotonin syndrome,

SMARTS

A

The combination of an MAOI and SSRI can precipitate a dangerous serotonin syndrome, characterized by myoclonus, hyperthermia, cardiovascular collapse, flushing, diarrhea and seizures.

Seizures

Myoclonus

ANS instability

Ridigidity

Temp increase

Sweating

29
Q

Headaches

Dizziness

Nervousness

Lightheadedness

These are all side effects of qhich anxiolytic?

A

Headaches

Dizziness

Nervousness

Lightheadedness

Buspirone

30
Q

___ is a long acting opioid antagonist used for opioid relapse prevention.

A

Naltrexone is a long acting opioid antagonist used for opioid relapse prevention.

31
Q

The most common chemicals and drugs that may cause acquired methemoglobinemia:

___ (e.g. benzocaine)

____

____ (e.g. dapsone, chloroquine, sulfonamides)

___ (used as additives to prevent meat from spoiling)

A BAN on methemoglobinemia

What is the treatment for methoglobinemia?

___ ___, acting as a cofactor to propagate the methemoglobin to hemoglobin transition

__ __, which may be beneficial by acting as an electron donor to limit reactive oxygen species formation or by altering iron levels

A

The most common chemicals and drugs that may cause acquired methemoglobinemia:

Anesthetics (e.g. benzocaine)

Benzenes

Antibiotics (e.g. dapsone, chloroquine, sulfonamides)

Nitrites (used as additives to prevent meat from spoiling)

Treatment for methomoglobinemia:

Methylene blue, acting as a cofactor to propagate the methemoglobin to hemoglobin transition

Vitamin C, which may be beneficial by acting as an electron donor to limit reactive oxygen species formation or by altering iron levels